GSK PLC (GSK)
42.30
+0.86
(+2.06%)
USD |
NYSE |
May 01, 13:15
GSK Market Cap: 86.41B for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 30, 2024 | 84.66B |
| April 29, 2024 | 85.01B |
| April 26, 2024 | 83.99B |
| April 25, 2024 | 83.58B |
| April 24, 2024 | 83.48B |
| April 23, 2024 | 84.25B |
| April 22, 2024 | 82.93B |
| April 19, 2024 | 81.21B |
| April 18, 2024 | 80.23B |
| April 17, 2024 | 80.90B |
| April 16, 2024 | 81.62B |
| April 15, 2024 | 82.74B |
| April 12, 2024 | 83.07B |
| April 11, 2024 | 83.36B |
| April 10, 2024 | 83.13B |
| April 09, 2024 | 83.52B |
| April 08, 2024 | 83.46B |
| April 05, 2024 | 84.15B |
| April 04, 2024 | 83.48B |
| April 03, 2024 | 84.87B |
| April 02, 2024 | 85.38B |
| April 01, 2024 | 86.67B |
| March 28, 2024 | 87.58B |
| March 27, 2024 | 87.83B |
| March 26, 2024 | 87.42B |
| Date | Value |
|---|---|
| March 25, 2024 | 87.50B |
| March 22, 2024 | 86.52B |
| March 21, 2024 | 85.97B |
| March 20, 2024 | 85.08B |
| March 19, 2024 | 85.87B |
| March 18, 2024 | 85.51B |
| March 15, 2024 | 85.61B |
| March 14, 2024 | 87.41B |
| March 13, 2024 | 87.98B |
| March 12, 2024 | 87.80B |
| March 11, 2024 | 87.09B |
| March 08, 2024 | 87.54B |
| March 07, 2024 | 88.43B |
| March 06, 2024 | 86.48B |
| March 05, 2024 | 86.44B |
| March 04, 2024 | 86.12B |
| March 01, 2024 | 85.28B |
| February 29, 2024 | 85.02B |
| February 28, 2024 | 85.91B |
| February 27, 2024 | 85.99B |
| February 26, 2024 | 85.91B |
| February 23, 2024 | 85.66B |
| February 22, 2024 | 85.54B |
| February 21, 2024 | 85.09B |
| February 20, 2024 | 85.26B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
58.29B
Minimum
Sep 27 2022
117.83B
Maximum
Apr 13 2022
82.36B
Average
80.78B
Median
Market Cap Benchmarks
| AstraZeneca PLC | 236.69B |
| Novo Nordisk A/S | 573.26B |
| Pfizer Inc | 150.43B |
| Sanofi SA | 123.52B |
| Moderna Inc | 41.77B |
Market Cap Related Metrics
| PE Ratio | 15.13 |
| PS Ratio | 2.442 |
| Price to Book Value | 5.082 |
| Price to Free Cash Flow | 16.74 |
| Price | 42.30 |
| Earnings Yield | 6.61% |
| Operating PE Ratio | 10.09 |
| Normalized PE Ratio | 13.83 |